Loiseau, A.; Boudon, J.; Oudot, A.; Moreau, M.; Boidot, R.; Chassagnon, R.; Mohamed Saïd, N.; Roux, S.; Mirjolet, C.; Millot, N.
Titanate Nanotubes Engineered with Gold Nanoparticles and Docetaxel to Enhance Radiotherapy on Xenografted Prostate Tumors. Cancers 2019, 11, 1962.
https://doi.org/10.3390/cancers11121962
AMA Style
Loiseau A, Boudon J, Oudot A, Moreau M, Boidot R, Chassagnon R, Mohamed Saïd N, Roux S, Mirjolet C, Millot N.
Titanate Nanotubes Engineered with Gold Nanoparticles and Docetaxel to Enhance Radiotherapy on Xenografted Prostate Tumors. Cancers. 2019; 11(12):1962.
https://doi.org/10.3390/cancers11121962
Chicago/Turabian Style
Loiseau, Alexis, Julien Boudon, Alexandra Oudot, Mathieu Moreau, Romain Boidot, Rémi Chassagnon, Nasser Mohamed Saïd, Stéphane Roux, Céline Mirjolet, and Nadine Millot.
2019. "Titanate Nanotubes Engineered with Gold Nanoparticles and Docetaxel to Enhance Radiotherapy on Xenografted Prostate Tumors" Cancers 11, no. 12: 1962.
https://doi.org/10.3390/cancers11121962
APA Style
Loiseau, A., Boudon, J., Oudot, A., Moreau, M., Boidot, R., Chassagnon, R., Mohamed Saïd, N., Roux, S., Mirjolet, C., & Millot, N.
(2019). Titanate Nanotubes Engineered with Gold Nanoparticles and Docetaxel to Enhance Radiotherapy on Xenografted Prostate Tumors. Cancers, 11(12), 1962.
https://doi.org/10.3390/cancers11121962